A subcutaneous version of Daiichi Sankyo’s AstraZeneca-partnered blockbuster antibody-drug conjugate (ADC) Enhertu could be ...

Alteogen Inc. said that it has entered into an exclusive license agreement with Daiichi Sankyo (DSKYF.PK). As per the terms of the ...

The nuclear fuel sample, the size of a grain of rice, was placed into a secure container Thursday, marking the end of the ...

Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous ...

After Donald Trump was re-elected US president, a screengrab of his 2023 interview with former Fox News host Tucker Carlson ...

An evacuee from Futaba Town in Fukushima Prefecture made a comment expressing concern about the first test retrieval of fuel ...

A robot tasked with navigating the wreckage inside Fukushima Daiichi's Unit 2 reactor has successfully retrieved a small ...

Tokyo Electric Power Company announced it has successfully completed the trial removal of a sample of fuel debris from the ...

Japan is accurately monitoring occupational radiation exposure of workers involved in handling ALPS-treated water at the Fukushima Daiichi Nuclear Power Station (FDNPS), the International Atomic ...

Daiichi Sankyo & AstraZeneca’s Enhertu receives 2024 Prix Galien USA Award for Best Biotechnology Product: Tokyo Monday, November 11, 2024, 09:00 Hrs [IST] Daiichi Sankyo and As ...

DAIICHI, a leading car seat company in Korea, has launched the portable car seat 'Easy Carry 2' and portable stroller 'The ...

Merck (NYSE: MRK) recently reported its Q3 results, with revenues and earnings exceeding the street estimates.